TNX-102 SL Holds Potential to Treat FM Symptoms, Phase 3 Trial Data Show
News
The investigational therapy TNX-102 SL (sublingual cyclobenzaprine) had significant beneficial impact on sleep quality and fatigue, although it did not reduce pain levels in patients with fibromyalgia, results from a ... Read more